Abiopharma

bioAffinity Technologies Announces Program to Advance Veteran Lung Health: Philips, bioAffinity Technologies and 4DMedical Highlight New Approaches to Lung Health Screening for U.S. Veterans

EquipmentShare Announces Launch of Private Offering of Notes

Morningstar Report Finds Semiliquid Fund Market Nears $600 Billion as Private Credit Loses Steam

NAPC Defense Completes Integration, Achieves May Operational Milestones, and Reaffirms $90 Million Revenue Projection for Fiscal 2027

QuickLogic to Participate in the Northland Growth Conference 2026

Outlook Therapeutics Announces FDA Acceptance of Resubmitted Biologics License Application for ONS-5010/LYTENAVA™ (bevacizumab-vikg) as a Treatment for Wet AMD

Calidi Biotherapeutics - Calidi Biotherapeutics Receives Positive Pre-IND Feedback from US FDA for CLD-401 Indicating Agreement on its Current Development Strategy as it Advances Towards a First-in-Human Study

Inspire Medical Systems, Inc. - Inspire Medical Systems, Inc. Announces Presence at SLEEP 2026 and Publication of PREDICTOR Study

Adial Pharmaceuticals Expands Executive Leadership Team and Closes PIPE Financing

BioAge Labs Announces First Participant Dosed in QUELL-CV, a Phase 2 Proof-of-Concept Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Patients at Elevated Cardiovascular Risk